(Q44334245)

2 December 2017

14-Methoxymetopon, a highly potent mu opioid agonist, biphasically affects ethanol intake in Sardinian alcohol-preferring rats (English)

1 reference

2 December 2017

0 references

Valentina Sabino

1

0 references

Pietro Cottone

object named as

Pietro Cottone

2

0 references

Helmut Schmidhammer

object named as

Helmut Schmidhammer

4

0 references

Luca Steardo

object named as

Luca Steardo

3

0 references

author name string

Eric P Zorrilla

5

1 reference

2 December 2017

8 March 2007

1 reference

2 December 2017

10

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

2 December 2017

192

1 reference

2 December 2017

4

1 reference

2 December 2017

537-546

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-007-0746-7

2 December 2017

0 references

cites work

ESBRA-Nordmann 1996 Award Lecture: ethanol drinking behaviour in Sardinian alcohol-preferring rats.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-007-0746-7

Synthesis and biological evaluation of 14-alkoxymorphinans. 20. 14-phenylpropoxymetopon: an extremely powerful analgesic

21 January 2018

1 reference

12 December 2020

Binding characteristics of [3H]14-methoxymetopon, a high affinity mu-opioid receptor agonist

1 reference

12 December 2020

14-Methoxymetopon, a very potent mu-opioid receptor-selective analgesic with an unusual pharmacological profile

1 reference

12 December 2020

Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats

1 reference

12 December 2020

Genetic sensitivity to effect of ethanol on dopaminergic system in alcohol preferring rats

1 reference

12 December 2020

Stimulation of locomotor activity by voluntarily consumed ethanol in Sardinian alcohol-preferring rats

1 reference

12 December 2020

The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog

1 reference

12 December 2020

Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats.

1 reference

12 December 2020

Morphine induced changes in ethanol-and water-intake are attenuated by the 5-HT3/4 antagonist tropisetron (ICS 205-930)

1 reference

12 December 2020

Micro1-opioid antagonist naloxonazine alters ethanol discrimination and consumption

1 reference

12 December 2020

Effects of moderate alcohol consumption on the central nervous system

1 reference

12 December 2020

Effect of urocortin and its interaction with adrenocorticotropin (ACTH) secretagogues on ACTH release.

1 reference

12 December 2020

Are peripheral opioid antagonists the solution to opioid side effects?

1 reference

12 December 2020

Intracerebroventricular morphine enhances alcohol consumption by rats.

1 reference

12 December 2020

Animal models of motivation for drinking in rodents with a focus on opioid receptor neuropharmacology

1 reference

12 December 2020

14-methoxymetopon, a potent opioid, induces no respiratory depression, less sedation, and less bradycardia than sufentanil in the dog.

1 reference

12 December 2020

Synthesis and biological evaluation of 14-alkoxymorphinans. 3. Extensive study on cyprodime-related compounds

1 reference

12 December 2020

Opiates and alcohol self-administration in animals.

1 reference

12 December 2020

Signal transduction efficacy of the highly potent mu opioid agonist 14-methoxymetopon

1 reference

12 December 2020

Separation of binding affinity and intrinsic activity of the potent mu-opioid 14-methoxymetopon.

1 reference

12 December 2020

Constant infusions of morphine and intakes of sweetened ethanol solution among rats

1 reference

12 December 2020

Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats

1 reference

12 December 2020

Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens

1 reference

12 December 2020

The effect of antagonists selective for mu- and delta-opioid receptor subtypes on alcohol consumption in C57BL/6 mice

1 reference

12 December 2020

Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hi

1 reference

12 December 2020

Highly potent novel opioid receptor agonist in the 14-alkoxymetopon series.

1 reference

12 December 2020

Role of the endogenous opioid system on the neuropsychopharmacological effects of ethanol: new insights about an old question

1 reference

12 December 2020

Effect of mu opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking.

1 reference

12 December 2020

Methylnaltrexone prevents morphine-induced kaolin intake in the rat.

1 reference

12 December 2020

Involvement of mu-opioid receptors in alcohol drinking by alcohol-preferring AA rats

1 reference

12 December 2020

The role of opioid-dopamine interactions in the induction and maintenance of ethanol consumption

1 reference

12 December 2020

Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial

1 reference

12 December 2020

Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment

1 reference

12 December 2020

Modulation of ethanol-intake by morphine: evidence for a central site of action

1 reference

12 December 2020

mu-Opioid receptor knockout mice do not self-administer alcohol

1 reference

12 December 2020

Opioid antagonists for alcohol dependence

1 reference

12 December 2020

Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice

1 reference

12 December 2020

Effects of 14-methoxymetopon, a potent opioid agonist, on the responses to the tail electric stimulation test and plus-maze activity in male rats: neuroendocrine correlates

1 reference

12 December 2020

A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat.

1 reference

12 December 2020

Endogenous opioids and alcohol dependence: opioid alkaloids and the propensity to drink alcoholic beverages

1 reference

12 December 2020

Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB1 receptor antagonist, SR 141716.

1 reference

12 December 2020

Endogenous opioid systems and alcohol addiction

1 reference

12 December 2020

10.1007/S00213-007-0746-7

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

17345066